Pharmaceutical Industry Information Portal


All posts by tag


Revenue of PROMOMED DM LLC for 9 months of 2021 increased by 194.74% and amounted to RUB 13.25 bln.

PROMOMED DM LLC publishes financial statements for 9 months of 2021 compiled in accordance with Russian Accounting Standards (RAS). According to the results of 9...

Artificial intelligence in medicine regulation

Regulators may need to apply a risk-based approach to assessing and regulating AI, which could be informed through exchange and collaboration in ICMRA.

Media allegations on the rise in medicine prices are manipulative

To date, the FAS Russia has already set 61 new economically reasonable prices for 22 medicines, ensuring their presence in the market.

Expert Articles